Pharmaceutical & BioTech

A leading biotechnology company focused on the development of oncology treatments, with a presence in over 30 countries.

• RPN partnered to navigate complex global regulatory landscapes, ensuring compliance and timely approvals for new cancer therapies.
• Managed a diverse landscape of international regulations, fast-paced market entry demands, and the challenge of maintaining consistent quality standards across borders.
• Implemented a customized regulatory strategy, leveraging on its global expertise and real-time regulatory intelligence for efficient submissions and approvals.

RPN partnered with the client in navigating diverse and complex regulatory requirements for multiple countries while keeping up with the fast-paced nature of oncology drug approvals.

The strive was to ensure uniform quality and compliance standards across all regions to maintain the integrity and efficacy of treatments. From a regulatory perspective, RPN managed efficient and timely submissions without compromising on the rigorous demands of oncology drug approval processes.

RPN and the client developed a comprehensive regulatory roadmap tailored to the specific needs of each country while aligning with the company’s global strategy. A centralized quality management system was established to ensure consistent compliance and quality across all markets. RPN leveraged on its extensive network of local regulatory experts to expedite submission and approval processes, ensuring timely market entry.

RPN achieved streamlined regulatory approvals in over 30 countries, significantly reducing time to market for critical oncology therapies. High compliance and quality standards were maintained, reinforcing the client’s reputation as a leader in cancer treatment. The outsourcing of the process enabled the client to focus on innovation and research while RPN managed the regulatory complexities, driving faster access to new markets.